Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patientsKURAMOCHI, Hidekazu; TANAKA, Koji; DANENBERG, Peter V et al.International journal of oncology. 2008, Vol 32, Num 1, pp 201-208, issn 1019-6439, 8 p.Article

Molecular determinants of cetuximab efficacyVALLBÖHMER, Daniel; WU ZHANG; GROSHEN, Susan et al.Journal of clinical oncology. 2005, Vol 23, Num 15, pp 3536-3544, issn 0732-183X, 9 p.Article

Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancerWU ZHANG; PRESS, Oliver A; LENZ, Heinz-Josef et al.Journal of clinical oncology. 2007, Vol 25, Num 24, pp 3726-3731, issn 0732-183X, 6 p.Article

DPD is a molecular determinant of capecitabine efficacy in colorectal cancerVALLBOHMER, Daniel; DONG YUN YANG; KURAMOCHI, Hidekazu et al.International journal of oncology. 2007, Vol 31, Num 2, pp 413-418, issn 1019-6439, 6 p.Article

FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor-expressing metastatic colorectal cancer patients treated with single-agent cetuximabWU ZHANG; GORDON, Michael; IQBAL, Syma et al.Journal of clinical oncology. 2007, Vol 25, Num 24, pp 3712-3718, issn 0732-183X, 7 p.Article

Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiationWU ZHANG; PARK, David J; LENZ, Heinz-Josef et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 600-605, issn 1078-0432, 6 p., 1Article